BNB Plus Corp.
BNBX•NASDAQ•Financials•Asset Management

About BNB Plus

BNB Plus Corp. provides digital asset treasury services. The company offers real-time data tracking of treasury performance and market indicators. The company, through its subsidiaries, also develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in the Americas, Europe, Asia, and internationally. The company engages in the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and nucleic acid production solutions for the biopharmaceutical and diagnostics industries, including LineaDNA, LineaRNAP, and LineaIVT, as well as the development and sale of a proprietary RNAP for use in the production of mRNA therapeutics. BNB Plus Corp. was formerly known as Applied DNA Sciences, Inc. and changed its name to BNB Plus Corp. in November 2025. The company was founded in 1983 and is based in Stony Brook, New York.

Company Information

SectorFinancials
IndustryAsset Management
CEOClay Shorrock
Founded1983
Employees48
CountryUnited States
Fiscal YearOctober - September

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyUSD - USD
TypeStock
SubtypeCommon Stock

Contact Information

Websitewww.bnbx.io
Phone631 240 8800
Address
50 Health Sciences Drive Stony Brook, New York 11790 United States

Corporate Identifiers

CIK0000744452
ISINUS03815U6073

Leadership Team & Key Executives

Clay D. Shorrock Esq., J.D.
President and Chief Executive Officer
Judith Murrah
Director, Strategic Transition Advisor and Secretary
Patrick Brian Horsman C.F.A.
Chief Investment Officer
Sanjay M. Hurry
Executive Director of Investor Relations and Corporate Communications